The Column Group
Venture capital · San Francisco, California, United States
Portfolio collected from the firm’s website, last checked Jun 28, 2026.Raises and exits come from each company’s own SEC and company records.
8Deep-tech portfolio4 active
4Portfolio exitsAcquired or listed
0Raises, 12 monthsLatest: Neurona Therapeutics
50Co-investorsShare a portfolio company
Portfolio · 8 companies
| Company | Sector | Status | Latest raise | Raised |
|---|---|---|---|---|
| Frontier Medicines | Biotech | Active | Jul 12, 2021 | $122.0M |
| Prelude Therapeutics | Biotech | Active | Aug 28, 2020 | $97.0M |
| Arcus Biosciences | Biotech | Active | — | — |
| Tortugas Neuroscience | Biotech | Active | — | — |
| Neurona Therapeutics | Biotech | Acquired | Apr 4, 2025 | $282.8M |
| Relay Therapeutics | Biotech | Public | Jan 10, 2024 | $30.0M |
| Imago BioSciences | Biotech | Acquired | Nov 20, 2020 | $105.8M |
| Turning Point Therapeutics | Biotech | Acquired | — | — |
Peer ranks
Portfolio size#53
Portfolio exits#49
Raises, 12 months#88
Co-investors#27
Co-investors
- Bay City CapitalVenture capital4 shared
- EcoR1 CapitalVenture capital4 shared
- Third Rock VenturesVenture capital4 shared
- Biotechnology Value FundVenture capital3 shared
- Boxer CapitalVenture capital3 shared
- Brookside CapitalVenture capital3 shared
- Frazier Healthcare PartnersVenture capital3 shared
- Gurnet Point CapitalVenture capital3 shared
- Mission Bay CapitalVenture capital3 shared
- Omega FundsVenture capital3 shared
Sectors
- Biotech8
Portfolios are collected from investors’ own websites and matched to tracked deep-tech companies by name; duplicate listings of the same firm are merged. Exits and raises come from each company’s own record: Form D through the latest filing.